 |
18 Diseases |  |
1 Trial |
|
1 Trial |  |
103 News |  |
| «12 |
- | Allergen immunotherapy / Stallergenes
Trial termination: Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children (clinicaltrials.gov) - Dec 19, 2011
P3, N=471, Terminated, Sponsor: Stallergenes
Study population being insufficiently symptomatic to enable differentiation between treatment and placebo. No safety concerns
- ||||||| Allergen immunotherapy / Stallergenes
Trial completion: Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis (clinicaltrials.gov) - Dec 19, 2011
P2/3, N=509, Completed, Sponsor: Stallergenes
No safety concerns Active, not recruiting --> Completed
- ||||| Allergen immunotherapy / Stallergenes, Staloral (allergy immunotherapy sublingual) / Stallergenes
Enrollment change: A Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Asthmatic Patients Allergic to House-dust Mites (clinicaltrials.gov) - Oct 10, 2011
P3, N=484, Completed, Sponsor: Stallergenes
Active, not recruiting --> Completed N=700 --> 484
- ||||||| Allergen immunotherapy / Stallergenes, Staloral (allergy immunotherapy sublingual) / Stallergenes
Trial completion: A Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Asthmatic Patients Allergic to House-dust Mites (clinicaltrials.gov) - Oct 10, 2011
P3, N=484, Completed, Sponsor: Stallergenes
N=700 --> 484 Active, not recruiting --> Completed
- ||||||| Allergen immunotherapy / Stallergenes
Trial completion: Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis (clinicaltrials.gov) - Sep 27, 2011
P3, N=280, Completed, Sponsor: Stallergenes
Active, not recruiting --> Completed Recruiting --> Completed
- ||||||| Allergen immunotherapy / Stallergenes
Trial completion: Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis (clinicaltrials.gov) - Sep 22, 2011
P3, N=420, Completed, Sponsor: Stallergenes
Recruiting --> Completed Recruiting --> Completed